📌 99.999% Survival Rate: Why Would You Ever Vaccinate Children Ages 5 To 11?
Editor’s Note: The CDC has admitted inflating the number of children deaths from COVID, so the survival odds are even greater than 99.999%
The Food and Drug Administration on Friday authorized Pfizer-BioNTech’s lower-dose Covid-19 vaccine for children ages 5 to 11, making it available to 28 million children in the United States.
The FDA’s move comes several days after its advisory committee voted 17-0, with one abstention, in favor of recommending the vaccine for children. The committee concluded that the benefits of vaccination outweigh its risks.
The advisory committee’s vote Tuesday had capped off a robust debate about the potential risks and benefits of the shots for younger children, as advisers cited concerns about the unknown rates of an inflammatory heart condition called myocarditis, and whether children would even need protection from Covid.
“It’s always nerve-wracking, I think, when you’re asked to make a decision for millions of children based on studies of only a few thousand children,” committee member Dr. Paul Offit, a vaccine researcher at Children’s Hospital of Philadelphia, said Tuesday during the discussion. “The question is, when do you know enough?
“With this vaccine, kids can go back to something that’s better than being locked at home on remote schooling, not being able to see their friends,” said Dr. Kawsar Talaat of Johns Hopkins University. “The vaccine will protect them and also protect our communities.” (Editor’s Note: They said the same thing about the older people who have been vaccinated and still have to wear masks, and many of them still get COVID-19)
The FDA Vote
FDA Voting Member:
“We’re never gonna learn about how safe the vaccine is until we start giving it.”
Video HT @politicalwilli pic.twitter.com/OMAph49Qow
— Techno Fog (@Techno_Fog) October 26, 2021
At present the only data we have were gathered from two Pfizer trials, one in which five- to eleven-year-olds were followed for two months and another with only six weeks of follow-up. Both were too small to find potential risks such as myocarditis. Those conditions won’t be studied until after the shot is approved for children. As reported by The Defender:
“Experts raised concerns over the lack of safety and efficacy data presented by Pfizer for use of its COVID vaccine in younger children, and they pointed to increasing safety signals based on reports to the Vaccine Adverse Event Reporting System (VAERS). They also questioned the need to vaccinate children — whose risk of dying from COVID is “almost nil” — at all.
According to Dr. Meryl Nass, member of the Children’s Health Defense Scientific Advisory Panel, Pfizer once again did not use all of the children who participated in the trial in their safety study.
‘Three thousand children received Pfizer’s COVID vaccine, but only 750 children were selectively included in the company’s safety analysis,’ Nass said.‘Studies in the 5-11 age group are essentially the same as the 12-15 group — in other words, equally brief and unsatisfying, with inadequate safety data and efficacy data, with no strong support for why this type of immuno-bridging analysis is sufficient … All serious adverse events were considered unrelated to the vaccine’ …
Dr. Jessica Rose, viral immunologist and biologist, told the panel EUA of biological agents requires the existence of an emergency and the nonexistence of alternate treatment. ‘There is no emergency and COVID-19 is exceedingly treatable,’ Rose said.
In a peer-reviewed study co-authored by Rose, myocarditis rates were significantly higher in people 13 to 23 years old within eight weeks of the COVID vaccine rollout. In 12- to15-year-olds, Rose said, reported cases of myocarditis were 19 times higher than background rates.
Rose said tens of thousands of reports have been submitted to VAERS for children ages 0 to 18. Rose explained: ‘In this age group, 60 children have died — 23 of them were less than 2 years old. It is disturbing to note that ‘product administered to patient of inappropriate age’ was filed 5,510 times in this age group. Two children were inappropriately injected, presumably by a trained medical professional, and subsequently died.'”
During the meeting Dr. Cody Meissner said about giving the vaccine to the young children:
- We don’t know the side effects
- The vaccine will probably not prevent infection
- It is not clear that it will reduce rates of transmission. We hope it will.
This type of opinion would be banned for misinformation on YouTube. https://t.co/Rc6iIZwVoO
— Dr. Joseph Mercola (@mercola) October 27, 2021
FDA Buries Data on Seriously Injured Children
“Pfizer’s clinical trial for children aged 12-15 included only 1,131 children who were vaccinated and at least one of those children suffered a devastating, life-altering injury which, despite incontrovertible proof and the cries of both the victim and her parents, has not been appropriately acknowledged by Pfizer or the FDA.Putting aside that one serious injury in a small trial should alone raise blaring alarm bells, one must ask: what other serious adverse events have been hidden and ignored by regulators?”
“For a virus that rarely harms children, the need to assure safety of the Covid-19 vaccine is high. A study with only 1,131 children is underpowered. It will not pick up anything but the most common adverse events.
If what Maddie suffered will occur in 1/1,000 children, that would result in 75,000 children in this country suffering this serious injury. If it happens 1/10,000 children, that is 7,500 suffering this serious injury.
It could be that the cure is worse than the disease. But that will only be known if there is a properly powered (a.k.a., sized) clinical trial with children.”
Per US Government data, there are 28,384,878 children between the ages of five and eleven as of 2020. The CDC doesn’t track COVID-19 for this specific age group, so using the data for all children under 18:
US Population ages 0 – 17 (2020): 72.8 million
Deaths In Ages Under 18 Involving COVID-19 (through 10/27/2021): 558
COVID-19 Survival Rate for children under 18: 99.9992%
Note: The deaths stated in the CDC data are “Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1.” This means that some of these deaths might not have actually involved COVID-19, and some of the cases could involve other co-morbidities.
Please think seriously before you vaccinate your children.
The Pfizer-BioNTech’s safety trials included about 5,000 children, which is not enough to identify rare side effects.
“We’re worried about a side effect that we can’t measure yet, but it’s probably real. We’re never going to learn how safe it is until we start giving it.”
— Committee member Dr. Eric Rubin, editor-in-chief of the New England Journal of Medicine and an infectious disease expert at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health.
There are many possible side effects from these COVID vaccines, such as myocarditis (inflammation of the heart), thrombocytopenia (low blood platelet count), severe allergic reactions, Bell’s Palsy and even death.
One member of the FDA panel abstained from voting, and he listed his reasons, primarily a brief three month evaluation period, natural immunity and a short protection period, in a tweet.
Statement on abstention from FDA adviser Michael Kurilla.
It really shows all of the complexity underneath the 17-0-1 vote. Don’t think many VRBPAC members would disagree with these points. pic.twitter.com/5sLDeS7fKB
— Emily Kopp (@emilyakopp) October 26, 2021
Given the evidence stated here, is it worth the risk to vaccinate children given the extremely minimal chance of severe symptoms from a possible COVID-19 infection?